NL-OMON38590已完成不适用
A pilot study of Study I: Distressing information, the Psychophysiological response and Recall. - PILOT-Study I: Distressing information, Psychophysiology and Recall.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •In order to be eligible to participate in Group 1 of this pilot study, a subject must meet all of the following criteria:
- •- Informed consent;
- •- Having had cancer or being treated for cancer with a curative intent, with the exception of having (had) esophageal cancer.
- •- Diagnosed with cancer within a time span of 1 to 5 years ago;;Group 2
- •In order to be eligible to participate in Group 2 of this pilot study, a subject must meet all of the following criteria:
- •- Informed consent;
- •- *Healthy*, meaning:
- •* Never having had cancer
- •* Currently not visiting any medical specialist for another serious medical condition
排除标准
- •Subjects are not eligible if one or more of the following criteria apply:
- •- Those who suffer from cardiovascular disease and/or hypertension (to prevent interference with psycho-physiological measurements);
- •- Those who suffer from an endocrine disorder, e.g. diabetes mellitus (to prevent interference with cortisol measures);
- •- Smoking > 20 cigarettes per week (to prevent interference with cortisol measures);
- •- No current use of corticosteroid containing medication, including ointments (to prevent interference with cortisol measures);
- •- Subjects who are not literate in Dutch;
- •- Subjects who have an uncorrectable hearing or vision problem;
- •- Age < 18 years
研究者
相似试验
招募中
不适用
Pilot-Studie I: Verontrustende informatie, Psycho-fysiologie en Geheugen.NL-OMON22694Academic Medical Center (AMC),Amsterdam, The Netherlands40
已完成
4 期
A study on the influence of obesity on the protection after influenza vaccination in children aged 9-17 years.Obesity in children and adolescentsResponse to influenza vaccinationInflammatory and Immune System - Normal development and function of the immune systemInflammatory and Immune System - Other inflammatory or immune system disordersDiet and Nutrition - ObesityACTRN12617001086358Women's and Children's Hospital44
已完成
1 期
A Phase I Clinical Study Evaluating the Safety, Tolerability and Pharmacokinetics of HSK21542 in Healthy VolunteersAcute and Chronic PainAnaesthesiology - Pain managementACTRN12619001739101Avance Clinical40
已完成
1 期
A randomised, controlled phase 1 study to investigate the safety and efficacy of orally administered squalamine in subjects with Motor Neuron DiseaseNeurological - Neurodegenerative diseasesMotor Neuron DiseaseACTRN12619000375156Wesley Medical Research12
招募中
1 期
Safety, Tolerability, Pharmacokinetics (including Food Effect) of Single Ascending Doses of SAR441121 in healthy male subjects.ACTRN12618001783213sanofi-aventis australia ptd ltd62
